Medical Properties Trust Inc (MPT) stock
MPTNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/3080% below fair value
$1.64+0.01 (+0.61%)
Close on Nov 19, 2026Market cap $979.41MP/E –Yield 19.51%
Medical Properties Trust gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Medical Properties Trust's gross profit for the twelve months ending Dec 31, 2025 was $881.72M, down 4.3% year over year. For fiscal 2025 it was $881.72M, down 4.3% from the year before. The highest annual figure on record is $1.44B in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $881.72M | -4.3% |
| FY2024 | Dec 31, 2024 | $921.38M | +21.0% |
| FY2023 | Dec 31, 2023 | $761.73M | -44.6% |
| FY2022 | Dec 31, 2022 | $1.38B | -4.7% |
| FY2021 | Dec 31, 2021 | $1.44B | +18.4% |
| FY2020 | Dec 31, 2020 | $1.22B | +77.7% |
| FY2019 | Dec 31, 2019 | $685.99M | -2.1% |
| FY2018 | Dec 31, 2018 | $700.35M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $247.01M | +73.5% |
| Q1 FY2026 | Mar 31, 2026 | $154.73M | -26.6% |
| Q4 FY2025 | Dec 31, 2025 | $258.91M | +18.8% |
| Q2 FY2025 | Jun 30, 2025 | $220.60M | -15.9% |
| Q1 FY2025 | Mar 31, 2025 | $142.39M | -38.2% |
| Q4 FY2024 | Dec 31, 2024 | $210.72M | -24.1% |
| Q3 FY2024 | Sep 30, 2024 | $217.99M | +29.6% |
| Q2 FY2024 | Jun 30, 2024 | $262.24M | -28.0% |
| Q1 FY2024 | Mar 31, 2024 | $230.43M | -34.3% |
| Q3 FY2023 | Sep 30, 2023 | $277.81M | -19.4% |
| Q1 FY2023 | Mar 31, 2023 | $168.15M | -46.8% |
| Q4 FY2022 | Dec 31, 2022 | $364.43M | -2.1% |
| Q3 FY2022 | Sep 30, 2022 | $350.53M | -7.5% |
| Q2 FY2022 | Jun 30, 2022 | $344.66M | -7.2% |
| Q1 FY2022 | Mar 31, 2022 | $315.81M | -1.5% |
| Q4 FY2021 | Dec 31, 2021 | $372.43M | +16.1% |
| Q3 FY2021 | Sep 30, 2021 | $378.79M | +70.1% |
| Q2 FY2021 | Jun 30, 2021 | $371.29M | +67.0% |
| Q1 FY2021 | Mar 31, 2021 | $320.72M | +52.7% |
| Q3 FY2020 | Sep 30, 2020 | $320.88M | +82.9% |
| Q1 FY2020 | Mar 31, 2020 | $222.66M | +184.7% |
| Q4 FY2019 | Dec 31, 2019 | $222.31M | +42.3% |
| Q3 FY2019 | Sep 30, 2019 | $210.01M | +13.6% |
| Q2 FY2019 | Jun 30, 2019 | $175.46M | – |
| Q1 FY2019 | Mar 31, 2019 | $78.22M | – |
| Q4 FY2018 | Dec 31, 2018 | $156.20M | – |
| Q3 FY2018 | Sep 30, 2018 | $184.82M | – |
See a number that looks wrong?